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Introduction: Percutaneous endovascular aneurysm repair (PEVAR) has been shown to be feasible; however, technical
success is variable, reported to be between 46.2% and 100%. The objective of this study was to quantify the learning curve
of the PEVAR closure technique and identify predictors of closure failure.
Methods: We reviewed patient- and procedure-related characteristics in 99 consecutive patients who underwent PEVAR
over a 30-month period in a single academic institution. A suture-mediated closure device (Proglide or Prostar XL) was
used. Forward stepwise logistic regression was used to investigate associations between the failure of the closure technique
and a number of patient and operative characteristics. To ensure objective assessment of the learning curve, a
time-dependent covariate measuring time in calendar quarters was introduced in the model. Poisson regression was used
to model the trend of observed failure events of the percutaneous technique over time.
Results: Overall PEVAR technical success was 82%. Type of closure device (P< .35), patient’s body mass index (P< .86),
type of anesthesia (P < .95), femoral artery diameter (P < .09), femoral artery calcification (P < .56), and sheath size as
measured in Fr (P < .17) did not correlate with closure failure rates. There was a strong trend for a decreasing number
of failure events over time (P< .007). The average decrease in the odds of technical failure was 24% per calendar quarter.
The predicted probability of closure failure decreased from 45% per patient at the time of the initiation of our PEVAR
program to 5% per patient at the end of the 30-month period. There were two postoperative access-related complications
that required surgical repair. Need for surgical cutdown in the event of closure failure prolonged the operative time by a
mean of 45 minutes (P < .001). No groin infections were seen in the percutaneous group or the failed group.
Conclusions: Technical failure can be reduced as the surgeon gains experience with the suture-mediated closure device
utilized during PEVAR. Previous experience with the Proglide device does not seem to influence the learning curve.
(J Vasc Surg 2013;57:72-6.)
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lAdvances in technology combined with smaller sheath
sizes to deliver large stent grafts have transformed abdom-
inal aortic surgery over the last decade. Endovascular exclu-
sion (EVAR) has become the first-line therapy in treating
abdominal aortic aneurysms (AAAs), and now percutane-
ous EVAR (PEVAR) is increasingly becoming more popu-
lar than surgical femoral cutdown (FC-EVAR) for stent
graft delivery. Multiple prospective studies1-8 and one ran-
domized study9 have shown the feasibility of PEVAR since
its introduction in 1999.10 PEVAR has been shown to
reduce groin wound infections and lymphoceles as well as
hematomas. On the other hand, PEVAR technical success
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72as been reported to be between 46% and 100%2-10 in
he literature. Large sheath size,2-4,6 obesity,2-4,6 and
emoral calcifications1-2,6 have been reported as predictors
f PEVAR technical failure. Operator’s inexperience has
een alluded to as a contributing factor for decreasing
echnical success.5 Only one study reports the impact of
urgeon experience on PEVAR outcomes; this study dem-
nstrated an odds ratio of 43.2 (P  .001) for early
onversion to FC-EVAR in the hands of inexperienced
perators (30 interventions).1
The purpose of our study was to examine the learn-
ng curve over time as well as identify predictors of failure
ince the initiation of our PEVAR program in March of
009.
ETHODS
Patient- and procedure-related characteristics were re-
iewed in the first 99 consecutive patients who underwent
EVAR (abdominal and thoracic) over a 30-month period
n a single academic institution since March of 2009. Ret-
ospective review of the data was performed at the Michael
. DeBakey Veterans Affairs Hospital in Houston, TX.
nstitutional Review Board approval from both Baylor Col-
ege of Medicine and the Michael E. DeBakey Veterans
ffairs hospital was obtained. All the cases were performed
n the operating room under either general, regional, or
ocal anesthesia with moderate sedation. All patients re-
eived preoperative intravenous antibiotics and a sterile
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Volume 57, Number 1 Bechara et al 73prep from the chest to the knees. Data were collected on
patients that were treated using femoral sheath size12 Fr.
Primary end points were technical success of percutaneous
access, FC-EVAR conversion to achieve hemostasis, type of
femoral artery calcifications, advertent outcomes of percu-
taneous failure, and causes of failure.
Patient selection. Since the initiation of the PEVAR
program in March of 2009, all patients undergoing aneu-
rysm exclusion were considered for PEVAR. The only
exclusion was the presence of common femoral artery an-
eurysm requiring repair and the need for femoral artery
reconstruction such as endarterectomy with patch angio-
plasty. Obesity, femoral calcifications, previous groin sur-
gery, type of stent graft device, and large sheath (20 Fr)
were not considered as a contraindication for PEVAR.
Femoral calcification was reported based on its distribution:
anterior, posterior, or circumferential calcifications. In ad-
dition to collecting data on body mass index (BMI), infor-
mation on common femoral artery (CFA) depth from the
skin was collected. This was done because BMI did not
reflect the accurate depth of the femoral vessels due to
different fat distribution among different patients. The
depth was measured as a vertical line from the anterior
abdominal wall to the CFA as described previously by
Smith et al.7 Femoral artery diameter was obtained by
measuring the inner diameter based on the preoperative
computed tomography angiography images.
Device and technique. Ultrasound-guided access of
bilateral CFA’s using Sonosite Titan ultrasound (Sonosite,
Bothell, Wash) was performed in all the cases. All patients
were heparinized during the procedure to a goal acti-
vated clotting time of 250 seconds. Protamine dose,
either full or half reversal relative to the heparin dose, was
administered at the end of the surgery. Two different
suture-mediated closure devices were used for the
PEVAR cases depending on the operator. Either the 6F
Perclose Proglide or the 10F Prostar XL was used (Ab-
bott Vascular, Redwood City, Calif). The Prostar XL was
used exclusively by one of the authors (C.F.B.); the
remaining authors are Proglide users. Only one Prostar
XL is used per femoral vessel or two Proglides, regardless
of sheath size. Since the Proglide device has a preknotted
suture and is routinely used for other endovascular
peripheral interventions, we examined the data to see
if prior experience affected the learning curve during
PEVAR in comparison to the Prostar device. At the time
of the PEVAR program initiation, none of the authors
had any prior experience with this technique using the
Proglide device. One of the authors (C.F.B.) had some
experience with the Prostar device, but it was limited to
less than five cases. However, all of the surgeons had
tremendous prior experience with Proglide (100 cases)
from using it during other endovascular peripheral inter-
ventions.
Our “preclose” technique for Prostar XL4 and Pro-
glide2 deployment and closure is similar to what has been
described by other authors except for a few modifications.
Since all femoral vessels were accessed using the ultrasound, Tngiography to confirm access location was not routinely
erformed. The CFA was accessed just above the profunda
rtery bifurcation in the middle of a healthy segment (Fig
). Blunt dissection was performed with a hemostat around
he sheath prior to any closure device deployment. The su-
ures were placed to the side and covered with heparinized
aline-soaked gauze. At the end of the surgery, the smaller
heath was removed first, followed by the larger sheath.
ost times, we start slowly infusing protamine during this
rocess. The suture is gently cinched down around the
heath by applying tension and countertension to avoid
ulling the sutures through the arteriotomy. The sutures
ere continuously irrigated during this process. Gentle
ressure on the access site was applied until all the prota-
ine was infused, and activated clotting time returned to
ormal level. All patients laid flat in the recovery room for 1
o 2 hours; both groins were examined prior to discharge to
he floor.
Statistics. Forward stepwise logistic regression was
sed to investigate the association between failure of the
losure technique and a number of patient and operative
haracteristics. To ensure objective assessment of the learn-
ng curve, a time-dependent covariate measuring time in
alendar quarters since the beginning of the PEVAR pro-
ram was introduced in the model. Poisson regression was
sed to model the trend of observed failure events of the
ercutaneous technique over time. Analysis was performed
ith Stata IC version 11.2 (StataCorp, College Station,
ig 1. Ultrasound is used to access the common femoral artery in
he middle of a healthy segment. Arrow pointing to tip of the
eedle.ex).
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Ninety-nine patients underwent PEVAR during the
study period. The charts were reviewed retrospectively to
assess the learning curve needed to reduce technical
failure of the percutaneous closure. All 99 aneurysms
were successfully treated with an endovascular stent
graft. Most of these aneurysms were located in the
infrarenal aorta (81 cases, 81.8%); 13 were either isolated
iliac aneurysms or with an infrarenal aneurysm, and five
were thoracic aneurysms. The majority of the PEVAR
cases were done under general anesthetic (69, 69.7%),
18 (18.2%) under spinal anesthesia, and 12 (12.1%)
under local/sedation.
The overall technical success rate for the percutaneous
closure was 81.8% (81 cases out of 99). The majority of the
cases, 16 cases, were intraoperative conversion to FC-
EVAR to achieve hemostasis. All of these cases except for
two were repaired primarily. The remaining two cases re-
quired a small bovine patch to repair the femoral artery.
Most of the failures were either due to suture partially
pulling through the arteriotomy or the inability to push the
knot all the way down to the level of the arteriotomy. There
were two postoperative access-related complications that
required surgical repair. One was common femoral artery
thrombosis on postoperative day 1 that required thrombec-
tomy and patch angioplasty, and the other was open repair
for pseudoaneurysm on postoperative day 2. Need for
surgical cutdown in the event of closure failure prolonged
the operative time by a mean of 45 minutes (P .001). No
groin infections were seen in the percutaneous group or the
failed group.
Type of closure device (P .35), BMI (P .86), use of
a hydrophilic sheath (P .69), type of anesthesia (P .95),
femoral artery diameter (P  .09), femoral artery calcifica-
tion (P .56), and sheath size as measured in Fr (P .17)
did not correlate with closure failure rates. The mean BMI
was 27.45 (range, 18-42.5), with 33 cases with BMI 30
and five cases with BMI 40. The distance from skin to
femoral vessels did not affect technical failure (P  .24).
The mean distance was 3.9 cm (range, 1.5-10.2 cm). We
used six different stent grafts to treat the 99 aneurysms. The
right common femoral artery median sheath size used was
18 Fr (range, 12-24) and 16 Fr (range, 12-24) for the left
common femoral artery.
The percutaneous failure rate over time was then exam-
ined. We found a strong trend for decreasing failure rate
over time (P  .007). The average decrease in the odds of
technical failure was found to be 24% per calendar quarter.
The probability of closure failure per patient over time was
also examined. The predicted probability of closure failure
decreased from 45% per patient at the time of the initiation
of our PEVAR program to 5% per patient at the end of the
30-month period. At the time of writing this article, it
decreased to 3%. The learning curve appeared to be
steepest during the first 18 months (Fig 2). Our data
showed that prior experience with the Proglide device does
not affect the learning curve. Actually, the learning curve eor the Proglide device is almost identical to the Prostar
urve (Fig 3).
ISCUSSION
Total PEVAR is gaining popularity among surgeons
nd interventionalists. Our study revealed similar findings
o a recently published data that obesity, large sheath size
in our study, large and small sheath), and femoral artery
alcifications are not associated with percutaneous fail-
re.11 The most striking finding in our study was the
emonstration of increasing technical success over time.
urrently, we tell our patients in clinic evaluated for
EVAR that there is 3% risk of conversion to open
emoral repair. Groin complications after FC-EVAR have
een reported to be20% in multiple studies.3,7,9 In order
o achieve technical success of80%, we found that at least
5 cases are needed, and approximately 30 cases are needed
o achieve technical success 90% (Fig 3). It was noted
reviously by Torsello et al, that an operator is considered
xperienced after deploying 30 Prostar devices.1,9 How-
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Volume 57, Number 1 Bechara et al 75numbers. Dosluoglu et al noted that there was no learning
curve using the Proglide device in a larger sheath if the
surgeon had prior experience with the device in closing
smaller sheaths.12 Interestingly, we found that prior expe-
rience with the Proglide closure device did not confer any
advantage. Our explanation is that the percutaneous tech-
nical success is multifactorial and depends on proficiency in
different steps: ultrasound-guided access, adequate suture
deployment, and knowledge of the closure device as well as
the closure technique. In addition, all these procedures
were performed in a single academic institution where
resident, fellows, and attendings participated to learn the
percutaneous closure technique. Clearly, the operator ex-
pertise in the above-mentioned steps varied, but it was
impossible to factor it into this study, except for the num-
ber of cases performed by each operator.
We will share some of the technical points that we
learned over time that we believe helped us achieve the
current technical success of 97%.
Several studies have demonstrated the importance of
ultrasound-guided femoral artery access to improve techni-
cal success as well as to decrease the conversion rate to open
femoral artery repair.4,11,13 This study cannot prove that,
since ultrasound-guided femoral access is routinely per-
formed for all endovascular cases done at our institution
regardless of sheath size or type of procedure. However, we
are advocates of ultrasound use for several reasons. Ultra-
sound allows the operator to access the CFA in the center of
a healthy segment to allow the needles and sutures to be
successfully deployed. This is crucial in patients with un-
usual calcifications and anatomy. In addition, the CFA is
always accessed just above where the profunda artery bifur-
cates. The femoral head is not used as a marker nor is a
diagnostic angiogram performed to confirm appropriate
access. If the main body of the device can be placed from
either side, we tend to place the large sheath in the CFA
with the lowest bifurcation to stay away from the inguinal
ligament. Sutures getting tangled in the inguinal ligament
can be a source of technical failure.11 The subcutaneous
tissue around the sheath should be dissected circumferen-
tially prior to the “preclose” technique all the way down to
the femoral vessels. This is particularly important in scarred
groins and patients with high CFA bifurcation where access
is most likely near or through the inguinal ligament. We do
not have enough numbers of groins with previous surgeries
in our data to make any sound conclusions, but we were
able to achieve hemostasis in closing a 22 Fr arteriotomy in
a patient with two prior groin surgeries. Prior groin surgery
was present in 6.8% of the PEVAR cases in one study, but it
did not affect technical success.11 Serial dilations of the
arteriotomy was not routinely performed in our study.
Starnes et al4 recommended closing the arteriotomy
with the larger sheath first to have the contralateral access
available in case an endovascular balloon is needed for
proximal control if conversion to open repair is needed. We
routinely close the smaller sheath first and start infusing
protamine slowly while closing the larger arteriotomy.
When pulling down the sutures, it is crucial to put tensionnd countertension to avoid pulling the sutures. This takes
ime and judgment to know howmuch tension is needed to
ull the sutures down. Irrigating the sutures during this
rocess helped slide the knot down.
Need for surgical cutdown in the event of closure
ailure prolonged the operative time by a mean of 45
inutes (P  .001). Blood loss and transfusion was not
ignificant. We typically do not remove the wire access
nless we are satisfied with the hemostasis. If conversion to
C-EVAR is performed, we place a sheath and sometimes
n occlusive balloon to achieve hemostasis while femoral
xposure is being performed. No groin infections were seen
n the percutaneous group or the failed group.
Some authors avoid using the Prostar device because
he suture is braided and puts it at risk for infection.14 All
ur procedures were performed in the operating room
nder strict sterile conditions, and all patients received
ntravenous antibiotics before and after surgery.
We believe training in the animal laboratory or attend-
ng training courses might help reduce the learning curve;
owever, our study did not look at these factors. This could
e an area for future research. Another limitation to our
tudy was the retrospective analysis of the data.
ONCLUSIONS
Technical failure can be reduced over time, as the
urgeon gains experience with the suture-mediated closure
evice utilized during PEVAR. Previous experience with
he Proglide device does not seem to influence the learning
urve. Currently, we tell our patients that there is3% risk
f conversion to open FC-EVAR with PEVAR.
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